-
Product Insights
NewInterleukin 2 Receptor Subunit Alpha – Drugs In Development, 2024
The Interleukin 2 Receptor Subunit Alpha pipeline drugs market research report outlays comprehensive information on the Interleukin 2 Receptor Subunit Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Dermatology, and Cardiovascular which include indications of Solid Tumor, Melanoma, Systemic Lupus Erythematosus, Autoimmune Disorders, Atopic Dermatitis (Atopic Eczema), Alopecia Areata, Pulmonary Arterial Hypertension, and Stroke....
-
Product Insights
NewADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 – Drugs In Development, 2024
The ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 pipeline drugs market research report outlays comprehensive information on the ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Hematological Disorders which include indications of Multiple Myeloma (Kahler Disease), Relapsed Multiple Myeloma, Systemic Lupus Erythematosus, Unspecified Immunological Disorders,...
-
Product Insights
NewGlucokinase – Drugs In Development, 2024
The Glucokinase pipeline drugs market research report outlays comprehensive information on the Glucokinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Ophthalmology, Hormonal Disorders, and Central Nervous System which include indications of Type 2 Diabetes, Type 1 Diabetes (Juvenile Diabetes), Uveitis, Hashimoto Thyroiditis, Graves Diseases, and Alzheimer's Disease. It also reviews key players involved in...
-
Product Insights
NewHIV Integrase – Drugs In Development, 2024
The HIV Integrase pipeline drugs market research report outlays comprehensive information on the HIV Integrase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease which include indications of Human Immunodeficiency Virus (HIV) Infections (AIDS), and Tuberculosis. It also reviews key players involved in HIV Integrase targeted therapeutics development with respective active and dormant or discontinued projects....
-
Product Insights
NewInterleukin 6 – Drugs In Development, 2024
The Interleukin 6 pipeline drugs market research report outlays comprehensive information on the Interleukin 6 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Oncology, Infectious Disease, and Ophthalmology which include indications of Rheumatoid Arthritis, Inflammation, Oncology, Lung Cancer, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome, Diabetic Macular Edema, and Uveitis. It...
-
Product Insights
NewInduced Myeloid Leukemia Cell Differentiation Protein Mcl 1 – Drugs In Development, 2024
The Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 pipeline drugs market research report outlays comprehensive information on the Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Infectious Disease which include indications of Oncology, Solid Tumor, and Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. It also reviews key players...
-
Product Insights
NewPlasminogen – Drugs In Development, 2024
The Plasminogen pipeline drugs market research report outlays comprehensive information on the Plasminogen targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Hematological Disorders, Dermatology, and Genetic Disorders which include indications of Acute Ischemic Stroke, Ischemic Stroke, Bleeding And Clotting Disorders, Hemostasis, Diabetic Foot Ulcers, and Congenital Plasminogen Deficiency. It also reviews key players involved in Plasminogen...
-
Product Insights
NewTumor Necrosis Factor Receptor Superfamily Member 1B – Drugs In Development, 2024
The Tumor Necrosis Factor Receptor Superfamily Member 1B pipeline drugs market research report outlays comprehensive information on the Tumor Necrosis Factor Receptor Superfamily Member 1B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Infectious Disease, and Musculoskeletal Disorders which include indications of Solid Tumor, Melanoma, Autoimmune Disorders, Inflammation, Infectious Disease, Coronavirus Disease 2019 (COVID-19), and...
-
Product Insights
NewReceptor Tyrosine Protein Kinase ERBB 3 – Drugs In Development, 2024
The Receptor Tyrosine Protein Kinase ERBB 3 pipeline drugs market research report outlays comprehensive information on the Receptor Tyrosine Protein Kinase ERBB 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Gastric Cancer. It also reviews key players involved in Receptor Tyrosine Protein Kinase ERBB 3 targeted therapeutics development...
-
Product Insights
NewDual Specificity Mitogen Activated Protein Kinase Kinase 2 – Drugs In Development, 2024
The Dual Specificity Mitogen Activated Protein Kinase Kinase 2 pipeline drugs market research report outlays comprehensive information on the Dual Specificity Mitogen Activated Protein Kinase Kinase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Genetic Disorders, Non Malignant Disorders, and Central Nervous System which include indications of Solid Tumor, Low-Grade Glioma, Neurofibromatoses Type I (Von...